Cargando…

Aryl hydrocarbon receptor (AHR) is a novel druggable pathway controlling malignant progenitor proliferation in chronic myeloid leukemia (CML)

Aryl Hydrocarbon Receptor (AHR) is an ubiquitous basic helix-loop-helix transcription factor, which is ligand-activated and involved in numerous biological processes including cell division, cell quiescence and inflammation. It has been shown that AHR is involved in normal hematopoietic progenitor p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gentil, Melanie, Hugues, Patricia, Desterke, Christophe, Telliam, Gladys, Sloma, Ivan, Souza, Lucas E. B., Baykal, Seda, Artus, Jerome, Griscelli, Frank, Guerci, Agnes, Johnson-Ansah, Hyacinthe, Foudi, Adlen, Bennaceur-Griscelli, Annelise, Turhan, Ali G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6084853/ https://www.ncbi.nlm.nih.gov/pubmed/30091999 http://dx.doi.org/10.1371/journal.pone.0200923

Ejemplares similares

ENOX2 NADH Oxidase: A BCR-ABL1-Dependent Cell Surface and Secreted Redox Protein in Chronic Myeloid Leukemia
por: Baykal, Seda, et al.
Publicado: (2023)

Modeling Global Genomic Instability in Chronic Myeloid Leukemia (CML) Using Patient-Derived Induced Pluripotent Stem Cells (iPSCs)
por: Telliam, Gladys, et al.
Publicado: (2023)

Global MicroRNA Profiling Uncovers miR-206 as a Negative Regulator of Hematopoietic Commitment in Human Pluripotent Stem Cells
por: Flamant, Stéphane, et al.
Publicado: (2019)

Embryonic Program Activated during Blast Crisis of Chronic Myelogenous Leukemia (CML) Implicates a TCF7L2 and MYC Cooperative Chromatin Binding
por: Desterke, Christophe, et al.
Publicado: (2020)

PPARγ Cistrome Repression during Activation of Lung Monocyte-Macrophages in Severe COVID-19
por: Desterke, Christophe, et al.
Publicado: (2020)

HLA-dependent heterogeneity and macrophage immunoproteasome activation during lung COVID-19 disease
por: Desterke, Christophe, et al.
Publicado: (2021)

Evidence of Antitumor and Antimetastatic Potential of Induced Pluripotent Stem Cell-Based Vaccines in Cancer Immunotherapy
por: Kishi, Masae, et al.
Publicado: (2021)

EGR1 dysregulation defines an inflammatory and leukemic program in cell trajectory of human-aged hematopoietic stem cells (HSC)
por: Desterke, Christophe, et al.
Publicado: (2021)

iPSC-Derived Embryoid Bodies as Models of c-Met-Mutated Hereditary Papillary Renal Cell Carcinoma
por: Hwang, Jin Wook, et al.
Publicado: (2019)

Case report: Long-term voluntary Tyrosine Kinase Inhibitor (TKI) discontinuation in chronic myeloid leukemia (CML): Molecular evidence of an immune surveillance
por: Imeri, Jusuf, et al.
Publicado: (2023)

Detection of Hematopoietic Stem Cell Transcriptome in Human Fetal Kidneys and Kidney Organoids Derived From Human Induced Pluripotent Stem Cells
por: Hwang, Jin Wook, et al.
Publicado: (2021)

Genomic landscape analyses of reprogrammed cells using integrative and non-integrative methods reveal variable cancer-associated alterations
por: Griscelli, Frank, et al.
Publicado: (2019)

Molecular investigation of adequate sources of mesenchymal stem cells for cell therapy of COVID‐19‐associated organ failure
por: Desterke, Christophe, et al.
Publicado: (2020)

iPSC-Derived Organoids as Therapeutic Models in Regenerative Medicine and Oncology
por: Turhan, Ali G., et al.
Publicado: (2021)

iPSC-Derived Hereditary Breast Cancer Model Reveals the BRCA1-Deleted Tumor Niche as a New Culprit in Disease Progression
por: Portier, Lucie, et al.
Publicado: (2021)

Deciphering Potential Molecular Signatures to Differentiate Acute Myeloid Leukemia (AML) with BCR::ABL1 from Chronic Myeloid Leukemia (CML) in Blast Crisis
por: Boucher, Lara, et al.
Publicado: (2023)

Modeling Blast Crisis Using Mutagenized Chronic Myeloid Leukemia-Derived Induced Pluripotent Stem Cells (iPSCs)
por: Imeri, Jusuf, et al.
Publicado: (2023)

Genomic instability of human embryonic stem cell lines using different passaging culture methods
por: Tosca, Lucie, et al.
Publicado: (2015)

Patient-Derived iPSCs Reveal Evidence of Telomere Instability and DNA Repair Deficiency in Coats Plus Syndrome
por: Oudrhiri, Noufissa, et al.
Publicado: (2022)

Leukemic stem cell persistence in chronic myeloid leukemia patients in deep molecular response induced by tyrosine kinase inhibitors and the impact of therapy discontinuation
por: Chomel, Jean Claude, et al.
Publicado: (2016)

Clinically silent indolent T‐cell leukemia
por: Janot, Clément, et al.
Publicado: (2018)

Identification of Spectral Modifications Occurring during Reprogramming of Somatic Cells
por: Sandt, Christophe, et al.
Publicado: (2012)

Morphological Analysis of Human Induced Pluripotent Stem Cells During Induced Differentiation and Reverse Programming
por: Courtot, Anne-Marie, et al.
Publicado: (2014)

Modeling the influence of stromal microenvironment in the selection of ENU-induced BCR-ABL1 mutants by tyrosine kinase inhibitors
por: Aggoune, Djamel, et al.
Publicado: (2014)

Non integrative strategy decreases chromosome instability and improves endogenous pluripotency genes reactivation in porcine induced pluripotent-like stem cells
por: Congras, Annabelle, et al.
Publicado: (2016)

Corrigendum: Non integrative strategy decreases chromosome instability and improves endogenous pluripotency genes reactivation in porcine induced pluripotent-like stem cells
por: Congras, Annabelle, et al.
Publicado: (2018)

Aryl Hydrocarbon Receptor (AHR) Ligands as Selective AHR Modulators (SAhRMs)
por: Safe, Stephen, et al.
Publicado: (2020)

The HOXB4 Homeoprotein Promotes the Ex Vivo Enrichment of Functional Human Embryonic Stem Cell-Derived NK Cells
por: Larbi, Aniya, et al.
Publicado: (2012)

The Role of the Aryl Hydrocarbon Receptor (AHR) in Immune and Inflammatory Diseases
por: Neavin, Drew R., et al.
Publicado: (2018)

The Role of Aryl Hydrocarbon Receptor (AhR) in Brain Tumors
por: Perepechaeva, Maria L., et al.
Publicado: (2020)

Tumor-Suppressive Functions of the Aryl Hydrocarbon Receptor (AhR) and AhR as a Therapeutic Target in Cancer
por: Elson, Daniel J., et al.
Publicado: (2023)

BMAL1 knockdown triggers different colon carcinoma cell fates by altering the delicate equilibrium between AKT/mTOR and P53/P21 pathways
por: Zhang, Yuan, et al.
Publicado: (2020)

Preventing germ cell death by inactivating aryl hydrocarbon receptor (AHR)
por: Esakky, P, et al.
Publicado: (2016)

The Role of Aryl-Hydrocarbon Receptor (AhR) in Osteoclast Differentiation and Function
por: Park, Robin, et al.
Publicado: (2020)

A mesenchymal glioma stem cell profile is related to clinical outcome
por: Balbous, A, et al.
Publicado: (2014)

Chronic circadian disruption modulates breast cancer stemness and immune microenvironment to drive metastasis in mice
por: Hadadi, Eva, et al.
Publicado: (2020)

BMAL1 Knockdown Leans Epithelial–Mesenchymal Balance toward Epithelial Properties and Decreases the Chemoresistance of Colon Carcinoma Cells
por: Zhang, Yuan, et al.
Publicado: (2021)

Ethyl Caffeate Can Inhibit Aryl Hydrocarbon Receptor (AhR) Signaling and AhR-Mediated Potentiation of Mast Cell Activation
por: Nguyen, Phuc-Tan, et al.
Publicado: (2023)

AHR2 Mutant Reveals Functional Diversity of Aryl Hydrocarbon Receptors in Zebrafish
por: Goodale, Britton C., et al.
Publicado: (2012)

Genetic dissection of endothelial transcriptional activity of zebrafish aryl hydrocarbon receptors (AHRs)
por: Sugden, Wade W., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_3kcfc01mc61opbv0negvlhpto9